1/31/2013

Colesevelam therapy was associated with lower fasting and postprandial glucose concentrations in type 2 diabetes patients on metformin monotherapy, a study in Diabetes found. Researchers also discovered colesevelam did not affect insulin concentration, secretion or action in patients.

Related Summaries